186 related articles for article (PubMed ID: 27603714)
1. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.
Fabbri C; Hosak L; Mössner R; Giegling I; Mandelli L; Bellivier F; Claes S; Collier DA; Corrales A; Delisi LE; Gallo C; Gill M; Kennedy JL; Leboyer M; Lisoway A; Maier W; Marquez M; Massat I; Mors O; Muglia P; Nöthen MM; O'Donovan MC; Ospina-Duque J; Propping P; Shi Y; St Clair D; Thibaut F; Cichon S; Mendlewicz J; Rujescu D; Serretti A
World J Biol Psychiatry; 2017 Feb; 18(1):5-28. PubMed ID: 27603714
[TBL] [Abstract][Full Text] [Related]
2. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic studies: a tool to improve antidepressant therapy.
Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
Fabbri C; Di Girolamo G; Serretti A
Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
[TBL] [Abstract][Full Text] [Related]
5. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
Fabbri C; Serretti A
Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
[TBL] [Abstract][Full Text] [Related]
8. Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study.
Schiele MA; Zwanzger P; Schwarte K; Arolt V; Baune BT; Domschke K
Int J Neuropsychopharmacol; 2021 Mar; 24(3):191-199. PubMed ID: 33125470
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of antidepressant response: A polygenic approach.
García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
[TBL] [Abstract][Full Text] [Related]
11. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Modifications of Major Depressive Disorder.
Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
[TBL] [Abstract][Full Text] [Related]
13. Gene × environment interactions in the prediction of response to antidepressant treatment.
Klengel T; Binder EB
Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
Miller DB; O'Callaghan JP
Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
[TBL] [Abstract][Full Text] [Related]
15. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
16. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response.
Zhou L; Zhu Y; Chen W; Tang Y
J Affect Disord; 2021 May; 286():80-86. PubMed ID: 33714174
[TBL] [Abstract][Full Text] [Related]
19. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R
Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990
[TBL] [Abstract][Full Text] [Related]
20. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
